Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary
Seiji Mabuchi(The University of Osaka), Tadashi Kimura(Sakai Municipal Hospital), Joseph R. Testa(Fox Chase Cancer Center), Kimihiko Ito(Yamagata University), Deborah A. Altomare(University of Central Florida), Robert A. Burger(Mersana Therapeutics (United States)), Masami Hayashi(Yamagata University), Chiaki Kawase(Yamagata University), Andres J. Klein–Szanto, Yukihiro Nishio, Ken‐ichirou Morishige(Gifu University), Yoshito Terai(Osaka Medical and Pharmaceutical University), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Kenjiro Sawada(Gynecologic Oncology Group)
Cited by 88
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
|Journal of Clinical Oncology|2007|880
American Society of Clinical Oncology Position Statement on Obesity and Cancer
|Journal of Clinical Oncology|2014|524